# Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Study · id `cardio:ct-nct01870401` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01870401](<https://clinicaltrials.gov/study/NCT01870401>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01870401

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 442 participants.

## Technical summary

Registry record NCT01870401. Randomized; single masking; primary purpose treatment. Start 2013-06-03 (actual); primary completion 2018-05-17 (actual). Results posted on 2020-08-12.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 442 participants (enrolled count; ClinicalTrials.gov record NCT01870401, source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)
- Started: 2013-06-03 (actual) (ClinicalTrials.gov record NCT01870401, source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)
- Primary completion: 2018-05-17 (actual) (ClinicalTrials.gov record NCT01870401, source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)
- Completion: 2021-06-22 (actual) (ClinicalTrials.gov record NCT01870401, source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)
- Results first posted: 2020-08-12 (ClinicalTrials.gov record NCT01870401, source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)
- Countries: United States; Austria; Belgium; Canada; Germany; Italy; Japan; Switzerland (ClinicalTrials.gov record NCT01870401, source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01870401-2022-02-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
- Condition: Critical Limb Ischemia
- Intervention (Device): Lutonix DCB
- Intervention (Device): Uncoated PTA Catheter
- Lead sponsor: C. R. Bard
- Lead sponsor class: INDUSTRY
- Collaborator: Bard Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: C. R. Bard (`cardio:org-c-r-bard`)

## Provenance

Content hash: 000ed802e55ea8abb4c6cdebcd21da8cae703b010b7e63561a9f199360f2b7c0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
